Description

Each vial from Owens Peptide Solutions provides 10mg of lyophilized Semaglutide for qualified scientific investigation. Semaglutide is modeled after human glucagon-like peptide-1 and is designed to interact selectively with the GLP-1 receptor.

Research Use Disclaimer:

For laboratory and research use only. Not intended for human or animal consumption, medical use, diagnostic use, veterinary use, or therapeutic application.

The compound includes molecular modifications that limit rapid degradation by DPP-4 and support reversible binding with albumin. These properties have made it relevant to experimental work involving sustained receptor activation, incretin-mediated communication, endocrine response models, and peptide pharmacology.

Published research findings depend on the selected model, concentration, and analytical method. They should not be interpreted as authorization for clinical or consumer use.